AAP IMPLANTATE (AAQ1.DE) Stock Fundamental Analysis

FRA:AAQ1 • DE000A3H2101

1.52 EUR
0 (0%)
Last: Feb 13, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to AAQ1. AAQ1 was compared to 65 industry peers in the Health Care Equipment & Supplies industry. While AAQ1 seems to be doing ok healthwise, there are quite some concerns on its profitability. While showing a medium growth rate, AAQ1 is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • AAQ1 had negative earnings in the past year.
  • AAQ1 had a negative operating cash flow in the past year.
  • In the past 5 years AAQ1 always reported negative net income.
  • In the past 5 years AAQ1 always reported negative operating cash flow.
AAQ1.DE Yearly Net Income VS EBIT VS OCF VS FCFAAQ1.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M

1.2 Ratios

  • With a Return On Assets value of -25.96%, AAQ1 is not doing good in the industry: 78.46% of the companies in the same industry are doing better.
  • The Return On Equity of AAQ1 (-38.70%) is worse than 75.38% of its industry peers.
Industry RankSector Rank
ROA -25.96%
ROE -38.7%
ROIC N/A
ROA(3y)-27.22%
ROA(5y)-27.6%
ROE(3y)-50.99%
ROE(5y)-51.91%
ROIC(3y)N/A
ROIC(5y)N/A
AAQ1.DE Yearly ROA, ROE, ROICAAQ1.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40 -60 -80 -100

1.3 Margins

  • With an excellent Gross Margin value of 87.45%, AAQ1 belongs to the best of the industry, outperforming 96.92% of the companies in the same industry.
  • AAQ1's Gross Margin has been stable in the last couple of years.
  • The Profit Margin and Operating Margin are not available for AAQ1 so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 87.45%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.81%
GM growth 5Y-0.65%
AAQ1.DE Yearly Profit, Operating, Gross MarginsAAQ1.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. Health

2.1 Basic Checks

  • AAQ1 does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for AAQ1 has been increased compared to 1 year ago.
  • The number of shares outstanding for AAQ1 has been increased compared to 5 years ago.
  • The debt/assets ratio for AAQ1 has been reduced compared to a year ago.
AAQ1.DE Yearly Shares OutstandingAAQ1.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
AAQ1.DE Yearly Total Debt VS Total AssetsAAQ1.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

  • Based on the Altman-Z score of 0.21, we must say that AAQ1 is in the distress zone and has some risk of bankruptcy.
  • AAQ1 has a Altman-Z score of 0.21. This is in the lower half of the industry: AAQ1 underperforms 72.31% of its industry peers.
  • A Debt/Equity ratio of 0.03 indicates that AAQ1 is not too dependend on debt financing.
  • AAQ1 has a Debt to Equity ratio of 0.03. This is amongst the best in the industry. AAQ1 outperforms 87.69% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Altman-Z 0.21
ROIC/WACCN/A
WACC7.07%
AAQ1.DE Yearly LT Debt VS Equity VS FCFAAQ1.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M

2.3 Liquidity

  • AAQ1 has a Current Ratio of 2.40. This indicates that AAQ1 is financially healthy and has no problem in meeting its short term obligations.
  • With a decent Current ratio value of 2.40, AAQ1 is doing good in the industry, outperforming 70.77% of the companies in the same industry.
  • AAQ1 has a Quick Ratio of 1.24. This is a normal value and indicates that AAQ1 is financially healthy and should not expect problems in meeting its short term obligations.
  • AAQ1 has a Quick ratio (1.24) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 2.4
Quick Ratio 1.24
AAQ1.DE Yearly Current Assets VS Current LiabilitesAAQ1.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 63.21% over the past year.
  • The Revenue has been growing slightly by 6.32% in the past year.
  • AAQ1 shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 0.78% yearly.
EPS 1Y (TTM)63.21%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%21.53%
Revenue 1Y (TTM)6.32%
Revenue growth 3Y0.1%
Revenue growth 5Y0.78%
Sales Q2Q%-3.32%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • Based on estimates for the next years, AAQ1 will show a quite strong growth in Revenue. The Revenue will grow by 11.66% on average per year.
EPS Next Y65%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year15.38%
Revenue Next 2Y22.14%
Revenue Next 3Y12.95%
Revenue Next 5Y11.66%

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
AAQ1.DE Yearly Revenue VS EstimatesAAQ1.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 10M 20M 30M
AAQ1.DE Yearly EPS VS EstimatesAAQ1.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -0.5 -1 -1.5 -2 -2.5

More info and screens

Find the best growth stocksShow best growing peers

0

4. Valuation

4.1 Price/Earnings Ratio

  • AAQ1 reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for AAQ1. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
AAQ1.DE Price Earnings VS Forward Price EarningsAAQ1.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 -20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
AAQ1.DE Per share dataAAQ1.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 0.4 0.6 0.8

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • AAQ1 does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

AAP IMPLANTATE

FRA:AAQ1 (2/13/2026, 7:00:00 PM)

1.52

0 (0%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-02
Earnings (Next)N/A
Inst Owners22.99%
Inst Owner ChangeN/A
Ins Owners10.14%
Ins Owner ChangeN/A
Market Cap22.37M
Revenue(TTM)12.20M
Net Income(TTM)-3.63M
Analysts42.22
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.83
P/FCF N/A
P/OCF N/A
P/B 2.39
P/tB 2.97
EV/EBITDA N/A
EPS(TTM)-0.35
EYN/A
EPS(NY)-0.07
Fwd EYN/A
FCF(TTM)-0.06
FCFYN/A
OCF(TTM)-0.02
OCFYN/A
SpS0.83
BVpS0.64
TBVpS0.51
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -25.96%
ROE -38.7%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 87.45%
FCFM N/A
ROA(3y)-27.22%
ROA(5y)-27.6%
ROE(3y)-50.99%
ROE(5y)-51.91%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.81%
GM growth 5Y-0.65%
F-Score6
Asset Turnover0.87
Health
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 32.08%
Cap/Sales 4.82%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.4
Quick Ratio 1.24
Altman-Z 0.21
F-Score6
WACC7.07%
ROIC/WACCN/A
Cap/Depr(3y)18.89%
Cap/Depr(5y)19.66%
Cap/Sales(3y)3.48%
Cap/Sales(5y)3.84%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)63.21%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%21.53%
EPS Next Y65%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)6.32%
Revenue growth 3Y0.1%
Revenue growth 5Y0.78%
Sales Q2Q%-3.32%
Revenue Next Year15.38%
Revenue Next 2Y22.14%
Revenue Next 3Y12.95%
Revenue Next 5Y11.66%
EBIT growth 1Y61.47%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year173.33%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y63.88%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y86.19%
OCF growth 3YN/A
OCF growth 5YN/A

AAP IMPLANTATE / AAQ1.DE FAQ

What is the fundamental rating for AAQ1 stock?

ChartMill assigns a fundamental rating of 2 / 10 to AAQ1.DE.


Can you provide the valuation status for AAP IMPLANTATE?

ChartMill assigns a valuation rating of 0 / 10 to AAP IMPLANTATE (AAQ1.DE). This can be considered as Overvalued.


What is the profitability of AAQ1 stock?

AAP IMPLANTATE (AAQ1.DE) has a profitability rating of 1 / 10.


Can you provide the expected EPS growth for AAQ1 stock?

The Earnings per Share (EPS) of AAP IMPLANTATE (AAQ1.DE) is expected to grow by 65% in the next year.